DaVita acquires transplant software company MedSleuth
Click Here to Manage Email Alerts
DaVita Inc. announced its acquired MedSleuth, a transplant software company known for connecting transplant candidates, transplant centers, physicians and care teams to improve kidney and liver transplant outcomes.
In a press release, DaVita shared its plans to utilize MedSleuth in its commitment to improve every stage of kidney transplantation.
“Kidney transplantation is a life-changing option for most people with kidney failure, one that’s limited today by supply and complexity,” Javier Rodriguez, CEO of DaVita, said in the release. “MedSleuth has built a powerful platform that can help increase patients’ access to transplantation. We’re looking forward to supporting the team to accelerate innovation and help streamline the transplant process for transplant candidates, transplant centers, physicians and care teams.”
Currently, the acquisition of MedSleuth includes its product Breeze and its paired exchange platform Matchgrid. The CEO and founder of MedSleuth, James Kalamas, intends to continue running the company under DaVita’s ownership.
“We knew DaVita was the best long-term home for MedSleuth because we share a common vision to increase access to transplantation,” Kalamas said in the release. “Together, we’ll continue reimagining the transplant experience to help improve the lives of transplant patients.”
Click Here to Manage Email Alerts